Lower Costs, More Cures Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Dec 9, 2019)
Lower Costs, More Cures Act of 2019
This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs.
The bill generally
- limits payment amounts for drugs and biologics under Medicare medical services,
- reduces cost-sharing under the Medicare prescription drug benefit,
- modifies certain authorities and requirements under the Medicaid Drug Rebate Program,
- revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and
- establishes several reporting requirements for drug manufacturers with respect to drug prices.
What just happenedDec 19, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Who’s behind it
- Introduced in HouseDec 9, 2019
- Dec 19, 2019Committee
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Administrative State, Regulatory Reform, and Antitrust Subcommittee - Dec 10, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Dec 9, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Dec 9, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Dec 9, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Dec 9, 2019IntroReferral1000
Introduced in House
Energy and Commerce Committee - Dec 9, 2019IntroReferralIntro-H
Introduced in House